Literature DB >> 28509240

Cytokine dynamics in a 14-year-old girl with tubulointerstitial nephritis and uveitis syndrome.

Jun Aoyagi1, Takahiro Kanai2, Takane Ito3, Jun Odaka3, Takashi Saito3, Mariko Y Momoi3.   

Abstract

Tubulointerstitial nephritis and uveitis (TINU) syndrome, which was first described in 1975, has been reported in more than 130 patients, mostly in adolescent or young women. Although data concerning the etiologic background of this inflammatory disease are limited, several humoral factors, including cytokines, have been reported in association with the disease. Here, we report a case of TINU in a 14-year-old girl, whose renal and ophthalmological improvement was associated with the decrease of serum levels of tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), and interleukin-8 (IL-8). This suggests the presence of T-cell-mediated immunity in this unique syndrome.

Entities:  

Keywords:  Cytokine dynamics; IFN-γ; IL-8; TINU; TNF-α

Year:  2013        PMID: 28509240      PMCID: PMC5413674          DOI: 10.1007/s13730-013-0084-z

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  20 in total

1.  Distinct T cell/renal tubular epithelial cell interactions define differential chemokine production: implications for tubulointerstitial injury in chronic glomerulonephritides.

Authors:  T Kuroiwa; R Schlimgen; G G Illei; I B McInnes; D T Boumpas
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

2.  In vitro and in vivo interleukin-8 production in human renal cortical epithelia.

Authors:  R L Schmouder; R M Strieter; R C Wiggins; S W Chensue; S L Kunkel
Journal:  Kidney Int       Date:  1992-01       Impact factor: 10.612

3.  Effect of interleukin-8 on glomerular sulfated compounds and albuminuria.

Authors:  E H Garin; L West; W Zheng
Journal:  Pediatr Nephrol       Date:  1997-06       Impact factor: 3.714

4.  Repeat renal biopsy in a girl with tubulointerstitial nephritis and uveitis syndrome.

Authors:  H Tanaka; K Suzuki; T Nakahata; T Tateyama; S Waga; E Ito
Journal:  Pediatr Nephrol       Date:  2001-11       Impact factor: 3.714

5.  [Effects of hypoxia and tumor necrosis factor-alpha on production of plasminogen activator inhibitor-1 in human proximal renal tubular cells].

Authors:  Kunio Torii; Hideki Kimura; Xuan Li; Toshiharu Okada; Toshio Imura; Fumio Furusaki; Tomoko Ono; Haruyoshi Yoshida
Journal:  Rinsho Byori       Date:  2005-03

Review 6.  The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1.

Authors:  R M Strieter; A E Koch; V B Antony; R B Fick; T J Standiford; S L Kunkel
Journal:  J Lab Clin Med       Date:  1994-02

Review 7.  Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis.

Authors:  J P Rerolle; A Hertig; G Nguyen; J D Sraer; E P Rondeau
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

8.  Elevation of serum Krebs von den Lunge-6 levels in patients with tubulointerstitial nephritis and uveitis syndrome.

Authors:  Satoru Kase; Nobuyoshi Kitaichi; Kenichi Namba; Akiko Miyazaki; Kazuhiko Yoshida; Kenji Ishikura; Masahiro Ikeda; Taiji Nakashima; Shigeaki Ohno
Journal:  Am J Kidney Dis       Date:  2006-12       Impact factor: 8.860

9.  Macrophage inflammatory protein-1beta and interleukin-8 associated with idiopathic steroid-sensitive nephrotic syndrome.

Authors:  Takahiro Kanai; Takanori Yamagata; Mariko Y Momoi
Journal:  Pediatr Int       Date:  2008-11-26       Impact factor: 1.524

10.  Regulation and production of IL-8 by human proximal tubular epithelial cells in vitro.

Authors:  J S Gerritsma; P S Hiemstra; A F Gerritsen; W Prodjosudjadi; C L Verweij; L A Van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1996-02       Impact factor: 4.330

View more
  1 in total

Review 1.  New Biomarkers in Acute Tubulointerstitial Nephritis: A Novel Approach to a Classic Condition.

Authors:  Laura Martinez Valenzuela; Juliana Draibe; Xavier Fulladosa; Juan Torras
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.